PEOPLE - VNUS Medical Technologies makes appointment:
This article was originally published in Clinica
Peter Osborne, who was appointed as interim CFO of VNUS Medical Technologies (San Jose, California) in October 2007, will remain in the position on a permanent basis and also becomes the vice-president of finance and administration. Mr Osborne is a former audit partner of Deloitte & Touche and has more than 25 years' executive financial experience. VNUS is a developer of devices for the minimally-invasive treatment of venous reflux disease.
You may also be interested in...
The US FDA tells manufacturers in two recent warning letters to get to the root cause of contamination problems and take a more proactive approach to cleaning and equipment maintenance.
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.